search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
A New Hope for Depression


o you or someone you know suffer from depression? If so, you know the illness can have devastating consequences for not only the person suf- fering, but their families and loved ones as well. Depression is a very serious condition that sadly, affects more than 16 million adults in the US. Until the past few years medication and psychotherapy have been the primary modalities used to treat depres- sion. Transcranial Magnetic Stimulation (TMS) offers another solution; one that does not involve medication and side effects. TMS therapy offers hope to people who suffer from depression.


D


Targeting the Brain TMS targets the brain directly - Tran-


scranial (through the cranium), Magnetic (with a strong magnet), Stimulation (rapid or slow pulses). The brain is an electrochemi- cal organ and TMS gets to the activity in the brain at a cellular level. TMS uses an MRI strength magnetic pulse to change the electrical activity in the brain. With depression the goal is to awaken (rap- idly stimulate) areas of the brain that are underactive. With anxiety the treatment focus is to calm or down-regulate (with low frequency stimulation) the areas that are overaroused. Illnesses such as anxiety, OCD, PTSD, migraines, Bipolar, addiction, cognitive decline and many more can be treated with TMS. Treatment can be tailored to an individual’s brain if the specific treatment site and brain activity levels are


28 ELM™ Maine - March/April 2019


understood. Using the results of an EEG recording (Electroencephalograph), the data if analyzed properly can produce a “brain map,” which details the electrical activity in an individual’s brain.


Neuroscience is advancing at a rapid


pace. Now, with technology that can look at the brain as a physical organ we as a cul- ture can begin to lift the stigma associated with mental health. When we think of de- pression as a “brain disease,” and not some personal flaw, we can begin to release the past belief that, “something is wrong with me.” We can compare the disease of dia- betes when the pancreas is not functioning properly to the disease of depression due to the brain’s malfunction. Diabetes and other illnesses do not carry the stigma like diseases of the brain. It is time to change the narrative about mental health.


Treatment for Depression


We see firsthand the effect that illnesses like depression can have on individuals as well as their families and loved ones. When the brain is not functioning properly one’s decision making is compromised. With poor choices our lives can become unbalanced and chaotic. Too often patients find us after suffering for many years with- out relief. The typical path for the treatment of depression is for doctors to prescribe an antidepressant. It may take many trials to find one that helps and while these treat- ments work for many people, unfortunately,


not all. In fact, in any single antidepressant trial only a minority of patients achieve full remission, and as trials of antidepressant medication increases, so can side effects and the potential for treatment failure. TMS is a proven option that is safe and effective.


In an open-label clinical trial 58% of patients significantly responded to treat- ment, and 37% achieved complete remis- sion of their depression symptoms with NeuroStar TMS machine. Among people followed for 12 months after acute treat- ment, 68% retained their response and 45% were still in remission. The NeuroStar TMS machine was the first TMS device to receive US Food and Drug Administration (FDA) clearance in 2008. It is the device most commonly found throughout the world and considered the, “gold standard.”


Despite these promising statistics and results, a common misconception is that TMS treatments are last-resort options when all else fails, but this isn’t the case. The American Psychiatric Association recom- mended TMS as a second-line treatment when they changed their guidelines for treating depression in 2010. Unlike elec- troconvulsive therapy (ECT), TMS is non- invasive and allows patients to continue their regular daily activities immediately following treatment sessions.


It’s a great option, and one many prefer,


as it’s also free from systemic side effects often seen with antidepressant medications.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36